Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc

Group 1 - Wolf Haldenstein Adler Freeman & Herz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (NASDAQ: FLGT) [1] - The investigation focuses on whether Fulgent Genetics and certain officers/directors engaged in securities fraud [4] - On February 28, 2025, Fulgent disclosed in its Form 10-K that it received a civil investigative demand from the Department of Justice (DOJ) regarding potential false claims submitted under the Uninsured Program [4] Group 2 - Wolf Haldenstein has over 125 years of legal expertise in securities litigation and a proven track record of protecting the rights of investors [4]